bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q
| BLUE Stock | USD 7.91 0.36 4.77% |
About 55% of Bluebird Bio's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Bluebird bio stock suggests that some investors are interested at this time. The current market sentiment, together with Bluebird Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Bluebird bio stock news signals to limit their universe of possible portfolio assets.
Bluebird |
SOMERVILLE, Mass., September 13, 2024--bluebird bio, Inc. today announced that it has completed the restatement of its consolidated financial statements for the year ended December 31, 2022, and for each of the first three quarters of 2022 and 2023. Today, the Company filed its Annual Report on Form 10-K for the year ended December 31, 2023 , including the restated information, and Form 10-Q for the quarter ended March 31, 2024 with
Read at finance.yahoo.com
 |
Bluebird Bio Fundamental Analysis
We analyze Bluebird Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bluebird Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bluebird Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Bluebird Bio is currently under evaluation in target price category among its peers.
Bluebird bio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bluebird Bio stock to make a market-neutral strategy. Peer analysis of Bluebird Bio could also be used in its relative valuation, which is a method of valuing Bluebird Bio by comparing valuation metrics with similar companies.
Peers
Bluebird Bio Related Equities
| PPCB | Propanc Biopharma | 108.33 | ||||
| MRSN | Mersana Therapeutics | 8.47 | ||||
| HEPA | Hepion Pharmaceuticals | 5.56 | ||||
| MDGL | Madrigal Pharmaceuticals | 3.67 | ||||
| TVTX | Travere Therapeutics | 2.93 | ||||
| AGIO | Agios Pharm | 2.40 | ||||
| PTCT | PTC Therapeutics | 2.06 | ||||
| VKTX | Viking Therapeutics | 0.78 | ||||
| YMAB | Y MAbs | 0.65 | ||||
| KRYS | Krystal Biotech | 0.15 | ||||
| SRPT | Sarepta Therapeutics | 0.87 | ||||
| CVAC | CureVac NV | 1.29 | ||||
| KPTI | Karyopharm Therapeutics | 2.94 | ||||
| VIR | Vir Biotechnology | 5.41 | ||||
| ZNTL | Zentalis Pharmaceuticals | 12.17 |
Complementary Tools for Bluebird Stock analysis
When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |